SPRO
Spero Therapeutics (SPRO)
$79
About Spero Therapeutics (SPRO)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Details
Daily high
$2.88
Daily low
$2.69
Price at open
$2.71
52 Week High
$3.22
52 Week Low
$0.65
Market cap
161.5M
Dividend yield
0.00%
Volume
938,967
Avg. volume
518,458
P/E ratio
11.45
Spero Therapeutics News
Details
Daily high
$2.88
Daily low
$2.69
Price at open
$2.71
52 Week High
$3.22
52 Week Low
$0.65
Market cap
161.5M
Dividend yield
0.00%
Volume
938,967
Avg. volume
518,458
P/E ratio
11.45